Hubert Hondermarck

Scientific Advisor at Cygnal Therapeutics

A biochemist and expert in cancer cell biology, Dr. Hondermarck is a professor at the School of Biomedical Sciences and Pharmacy at the University of Newcastle in Australia. He received his Ph.D. in neurobiochemistry from the University of Lille in France and completed his postdoctoral research at the University of California, Irvine. He founded a research unit at the French Institute of Health and Medical Research and led that unit for 10 years before he joined the University of Newcastle in 2011. He has published more than 100 articles over his career as a researcher.

Dr. Hondermarck has uncovered the importance of neurotrophic factors secreted by cancer cells that, in turn, attract and recruit neuronal processes to the tumor microenvironment.


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Cygnal Therapeutics

Founded in 2017 by Flagship Pioneering, Cygnal Therapeutics is the first company to build a platform to develop drugs in the field of exoneural biology.


Industries

Employees

11-50

Links